Search results
The State of IBM Research. No effective treatment for inclusion body myositis (IBM), a neurologic disorder that rock star Peter Frampton was diagnosed with in 2015, has been found so far, and several drugs have proved disappointing in clinical trials.
In 2019, Peter Frampton revealed his inclusion body myositis (IBM) diagnosis. He’s now spoken about the impact the autoimmune disease is having on the chances of him being able to complete his last tour, which was scheduled for 2020 and delayed due to the pandemic.
Nov 26, 2019 · Four years earlier, Frampton had been diagnosed with inclusion body myositis, a degenerative muscle disorder that would gradually rob him of his ability to play guitar.
Feb 23, 2019 · During an interview on CBS This Morning: Saturday, Frampton, 68, shared that he suffers from a rare degenerative muscular disease, Inclusion-Body Myositis. He was first diagnosed with...
This is remarkable for two reasons: first, he has an autoimmune disease called inclusion body myositis (IBM) that affects his muscles. And second: although he has experienced some weakness and loss of function in larger muscles, his fingers still work great!
The Peter Frampton Myositis Research Fund at Johns Hopkins has been established to support Inclusion Body Myositis (IBM) research. Help us find a cure!
Feb 23, 2019 · Peter Frampton Talks Degenerative Muscle Disease Diagnosis, Farewell Tour. "In a year's time, I might not be able to play," says Frampton, who was diagnosed with Inclusion-Body Myositis. "I...
